Cynthia G Sawyez Selected Research

naringenin

1/2019	Naringenin enhances the regression of atherosclerosis induced by a chow diet in Ldlr-/- mice.
1/2019	Naringenin Supplementation to a Chow Diet Enhances Energy Expenditure and Fatty Acid Oxidation, and Reduces Adiposity in Lean, Pair-Fed Ldlr-/- Mice.
1/2018	Intervention with citrus flavonoids reverses obesity and improves metabolic syndrome and atherosclerosis in obese Ldlr-/- mice.
6/2015	Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21.
3/2013	Naringenin prevents cholesterol-induced systemic inflammation, metabolic dysregulation, and atherosclerosis in Ldlr⁻/⁻ mice.
4/2010	Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice.
10/2009	Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cynthia G Sawyez Research Topics

Disease

9	Atherosclerosis 01/2019 - 04/2010
9	Insulin Resistance 01/2019 - 10/2009
8	Inflammation (Inflammations) 11/2020 - 03/2013
7	Obesity 11/2020 - 04/2010
5	Dyslipidemias (Dyslipidemia) 01/2016 - 10/2009
5	Hyperinsulinism (Hyperinsulinemia) 06/2015 - 10/2009
4	Non-alcoholic Fatty Liver Disease 12/2020 - 01/2016
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 10/2009
4	Hyperlipidemias (Hyperlipidemia) 01/2016 - 04/2010
2	Fibrosis (Cirrhosis) 11/2020 - 01/2019
2	Ischemia 01/2019 - 01/2016
2	Body Weight (Weight, Body) 01/2019 - 01/2017
2	Hepatocellular Carcinoma (Hepatoma) 01/2016 - 05/2011
2	Hyperglycemia 01/2014 - 01/2014
1	Weight Loss (Weight Reduction) 12/2020
1	Weight Gain 01/2019
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018
1	Vascular Diseases (Vascular Disease) 01/2016
1	Vascular System Injuries 01/2016
1	Hypoxia (Hypoxemia) 01/2016
1	Glucose Intolerance 06/2015

Drug/Important Bio-Agent (IBA)

10	LipidsIBA 12/2020 - 12/2012
7	naringeninIBA 01/2019 - 10/2009
6	Glucose (Dextrose)FDA LinkGeneric 12/2020 - 10/2009
6	CholesterolIBA 01/2019 - 10/2009
5	FlavonoidsIBA 01/2019 - 04/2010
5	Fatty Acids (Saturated Fatty Acids)IBA 01/2018 - 10/2009
4	LDL Receptors (LDL Receptor)IBA 01/2018 - 10/2009
4	Lipoproteins (Lipoprotein)IBA 01/2016 - 10/2009
3	Triglycerides (Triacylglycerol)IBA 11/2020 - 10/2009
3	Insulin (Novolin)FDA Link 01/2014 - 05/2011
3	ApolipoproteinsIBA 05/2011 - 10/2009
2	didemninsIBA 11/2020 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 11/2020 - 01/2016
2	Niacin (Nicotinic Acid)FDA LinkGeneric 01/2019 - 01/2016
2	8- hydroxy- 2,2,14,14- tetramethylpentadecanedioic acidIBA 01/2018 - 01/2017
2	nobiletinIBA 01/2018 - 05/2011
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2014 - 10/2009
2	GW 501516IBA 01/2014 - 01/2014
1	Peptide Elongation Factors (Elongation Factor)IBA 11/2020
1	Vitamin D FDA LinkGeneric 01/2019
1	LDL CholesterolIBA 01/2018
1	oxidized low density lipoproteinIBA 01/2018
1	ATP Citrate (pro-S)-Lyase (Citrate Synthase, ATP)IBA 01/2017
1	Oleic Acid (Oleate)IBA 01/2016
1	Endoplasmic Reticulum Chaperone BiPIBA 01/2016
1	Oxygen (Dioxygen)IBA 01/2016
1	PalmitatesIBA 01/2016
1	matrigelIBA 01/2016
1	fibroblast growth factor 21IBA 06/2015
1	Dietary CholesterolIBA 03/2013
1	VLDL LipoproteinsIBA 12/2012
1	CytokinesIBA 12/2012
1	very low density lipoprotein triglycerideIBA 05/2011
1	PPAR alphaIBA 10/2009
1	Sterol Regulatory Element Binding Protein 1IBA 10/2009
1	Cholesterol Esters (Cholesteryl Esters)IBA 10/2009
1	PPAR gammaIBA 10/2009

Therapy/Procedure

2	Caloric Restriction 12/2020 - 01/2016
2	Therapeutics 01/2018 - 01/2016
1	Injections 01/2016
1	Fat-Restricted Diet (Diet, Fat Restricted) 03/2013